외과 수술 시장 : 수술 유형, 의료기기 유형, 용도, 최종 사용자별 - 세계 시장 예측(2026-2032년)

The Surgical Procedures Market is projected to grow by USD 1,524.47 billion at a CAGR of 6.45% by 2032.

Surgical procedures are a core measure of health system capacity, spanning emergency, elective, oncologic, cardiovascular, orthopedic, neurosurgical, obstetric, and minimally invasive interventions. The Lancet Commission on Global Surgery estimated that more than 300 million operations are performed worldwide each year, while billions of people still lack timely access to safe and affordable surgical care.

Demand is being reinforced by population aging, chronic disease prevalence, cancer incidence, trauma burden, cesarean section needs, and broader insurance coverage. For industry stakeholders, the surgical procedures landscape is shifting from volume-led care toward measurable outcomes, operating room efficiency, infection prevention, value-based procurement, digital workflow integration, and equitable access.

Transformative Shifts in the Surgical Procedures Landscape

The surgical procedures ecosystem is being reshaped by minimally invasive surgery, robotic-assisted platforms, image-guided interventions, enhanced recovery protocols, and the migration of eligible procedures to ambulatory surgery centers. These shifts are supported by payer pressure to reduce length of stay and by clinical evidence showing that less invasive approaches can lower complications, reduce hospital stays, and accelerate recovery when appropriately applied.

At the same time, hospitals are addressing workforce shortages, anesthesia availability, sterile processing constraints, supply chain resilience, and operating room utilization. Regulatory scrutiny, device traceability, cybersecurity, sustainability requirements, and clinical quality reporting are now central to capital equipment decisions and surgical service line strategy.

Cumulative Impact of Artificial Intelligence on Surgery

Artificial intelligence is moving from experimentation to practical surgical workflow support. FDA public data show hundreds of AI and machine learning-enabled medical devices have been authorized in the United States, with the largest concentration in radiology, where imaging supports surgical planning, triage, navigation, and follow-up.

The cumulative impact extends beyond the operating room. AI is being used for preoperative risk stratification, surgical imaging interpretation, scheduling optimization, instrument tracking, documentation, revenue cycle coding, postoperative complication prediction, and remote recovery monitoring. Adoption depends on clinical validation, clinician oversight, data governance, bias monitoring, interoperability, cybersecurity, and clear accountability for safety-critical decisions.

Key Regional Insights Across Surgical Procedures

North America remains a high-adoption region for advanced surgical procedures, supported by large hospital networks, ambulatory surgery center expansion, FDA-regulated device innovation, and reimbursement models that increasingly reward efficiency and outcomes. Europe combines universal coverage, strong specialist networks, and EU Medical Device Regulation requirements, creating a quality-driven but compliance-intensive environment for surgical devices, implants, and digital surgical technologies.

Asia-Pacific is expanding as China, India, Japan, South Korea, Australia, and ASEAN health systems invest in hospitals, cancer care, cardiovascular services, trauma systems, and minimally invasive capabilities. Latin America is led by Brazil and Mexico, where major urban centers support complex surgical care, although uneven public access and workforce distribution remain persistent constraints. The Middle East, especially GCC systems, is investing in tertiary care, digital hospitals, specialist workforce development, and medical tourism, while Africa's opportunity is defined by closing infrastructure, workforce, anesthesia, blood supply, and affordability gaps identified by global surgery research.

Key Group Insights: ASEAN, GCC, EU, BRICS, G7, and NATO

ASEAN surgical demand is rising with urbanization, private hospital growth, and government efforts to expand universal health coverage, although specialist availability, perioperative capacity, and rural access gaps remain. The GCC is prioritizing high-acuity surgical capacity, digital hospitals, international accreditation, and care localization, supported by national health transformation programs and investments in oncology, cardiology, orthopedics, transplant services, and trauma care.

The European Union emphasizes quality, safety, post-market surveillance, and device compliance under MDR, while BRICS countries represent substantial procedure volume due to population scale, expanding hospital infrastructure, and improving access to insured care. G7 markets lead in robotic surgery, AI-enabled diagnostics, advanced imaging, infection prevention, and outcomes measurement. NATO countries are also strengthening medical readiness, military-civilian trauma systems, emergency surgery preparedness, and medical supply chain resilience due to renewed focus on civil preparedness and defense health capacity.

Key Country Insights for Priority Surgical Markets

The United States leads in ambulatory surgery, robotics, specialty procedures, advanced imaging, and AI-enabled care pathways, while Canada emphasizes publicly funded access, surgical wait-time management, and provincial capacity planning. Mexico and Brazil are important Latin American procedure hubs, with private sector growth alongside public system capacity constraints and regional access disparities. In Europe, the United Kingdom, Germany, France, Italy, and Spain combine mature surgical infrastructure with aging populations, cancer care demand, and persistent elective backlog pressures; Russia maintains broad surgical capacity but faces technology access, procurement, and modernization challenges.

China is scaling surgical infrastructure, oncology capacity, and domestic medtech production, while India is expanding high-volume procedure access through public insurance programs and private hospital networks. Japan's aging population sustains strong demand for oncology, cardiovascular, gastrointestinal, and orthopedic surgery, supported by high clinical quality expectations. Australia maintains advanced surgical quality standards and strong public-private care delivery, while South Korea is recognized for technology adoption, specialty care, minimally invasive procedures, and medical tourism competitiveness.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize surgical pathways that improve measurable outcomes, including reduced length of stay, lower infection rates, fewer readmissions, fewer avoidable complications, and faster recovery. Investment decisions should align robotics, endoscopy, imaging, anesthesia, sterilization, implants, consumables, and digital platforms with validated service line demand rather than isolated technology acquisition.

Vendors should also strengthen workforce training, credentialing, AI governance, cybersecurity, supply chain redundancy, sterile processing performance, and value-based contracting. Partnerships with hospitals, payers, academic centers, public agencies, and regulators can accelerate evidence generation, while localized affordability models are essential for emerging markets where surgical access remains constrained.

Research Methodology and Evidence Base

This executive summary is based on triangulation of publicly available and widely cited sources, including the World Health Organization, the Lancet Commission on Global Surgery, OECD health statistics, national health agencies, FDA AI and medical device resources, peer-reviewed surgical literature, global burden of disease evidence, and recognized policy frameworks.

The methodology emphasizes verified indicators such as procedure access, demographic drivers, regulatory developments, reimbursement trends, hospital capacity, workforce availability, technology adoption, surgical safety initiatives, and regional health expenditure patterns. No unsupported proprietary market-size claims are used; insights are synthesized to support strategic planning, and evidence-based executive decision-making.

Conclusion: Future Outlook for Surgical Procedures

Surgical procedures are entering a new phase defined by precision, digitization, access expansion, infection prevention, and outcome accountability. Minimally invasive approaches, robotic systems, AI-enabled decision support, advanced imaging, enhanced recovery protocols, and ambulatory care models are changing how procedures are planned, delivered, monitored, and reimbursed.

The strongest opportunities will favor organizations that combine clinical evidence, operational excellence, responsible AI, regulatory readiness, and region-specific access strategies. As global demand rises, success will depend on improving safety, affordability, workforce readiness, supply resilience, and measurable patient outcomes across both mature and emerging surgical markets.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Definition
• 1.3. Market Segmentation & Coverage
• 1.4. Years Considered for the Study
• 1.5. Currency Considered for the Study
• 1.6. Language Considered for the Study
• 1.7. Key Stakeholders

2. Research Methodology

• 2.1. Introduction
• 2.2. Research Design
  • 2.2.1. Primary Research
  • 2.2.2. Secondary Research
• 2.3. Research Framework
  • 2.3.1. Qualitative Analysis
  • 2.3.2. Quantitative Analysis
• 2.4. Market Size Estimation
  • 2.4.1. Top-Down Approach
  • 2.4.2. Bottom-Up Approach
• 2.5. Data Triangulation
• 2.6. Research Outcomes
• 2.7. Research Assumptions
• 2.8. Research Limitations

3. Executive Summary

• 3.1. Introduction
• 3.2. CXO Perspective
• 3.3. Market Size & Growth Trends
• 3.4. Market Share Analysis, 2025
• 3.5. FPNV Positioning Matrix, 2025
• 3.6. New Revenue Opportunities
• 3.7. Next-Generation Business Models
• 3.8. Industry Roadmap

4. Market Overview

• 4.1. Introduction
• 4.2. Industry Ecosystem & Value Chain Analysis
  • 4.2.1. Supply-Side Analysis
  • 4.2.2. Demand-Side Analysis
  • 4.2.3. Stakeholder Analysis
• 4.3. Market Dynamics
  • 4.3.1. Key Drivers
  • 4.3.2. Key Restraints
  • 4.3.3. Key Opportunities
  • 4.3.4. Key Challenges
• 4.4. Porter's Five Forces Analysis
• 4.5. PESTLE Analysis
• 4.6. Market Outlook
  • 4.6.1. Near-Term Market Outlook (0-2 Years)
  • 4.6.2. Medium-Term Market Outlook (3-5 Years)
  • 4.6.3. Long-Term Market Outlook (5-10 Years)
• 4.7. Go-to-Market Strategy

5. Market Insights

• 5.1. Consumer Insights & End-User Perspective
• 5.2. Consumer Experience Benchmarking
• 5.3. Opportunity Mapping
• 5.4. Distribution Channel Analysis
• 5.5. Pricing Trend Analysis
• 5.6. Regulatory Compliance & Standards Framework
• 5.7. ESG & Sustainability Analysis
• 5.8. Disruption & Risk Scenarios
• 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Surgical Procedures Market, by Procedure Type

• 7.1. Minimally Invasive
  • 7.1.1. Endoscopy
  • 7.1.2. Laparoscopy
• 7.2. Open
  • 7.2.1. Major Open
  • 7.2.2. Minor Open

8. Surgical Procedures Market, by Device Type

• 8.1. Consumables
  • 8.1.1. Drapes
    • 8.1.1.1. Disposable Drapes
    • 8.1.1.2. Reusable Drapes
  • 8.1.2. Surgical Sealants
  • 8.1.3. Sutures
    • 8.1.3.1. Absorbable Sutures
    • 8.1.3.2. Non-Absorbable Sutures
• 8.2. Implants
  • 8.2.1. Cardiovascular Implants
  • 8.2.2. Neurological Implants
  • 8.2.3. Orthopedic Implants
• 8.3. Instruments
• 8.4. Visualization Equipment
  • 8.4.1. Endoscopes
  • 8.4.2. Surgical Microscopes

9. Surgical Procedures Market, by Application

• 9.1. Cardiovascular
  • 9.1.1. Bypass Surgery
  • 9.1.2. Stent Placement
  • 9.1.3. Valve Repair
• 9.2. General Surgery
• 9.3. Neurology
  • 9.3.1. Craniotomy
  • 9.3.2. Spinal Decompression
• 9.4. Ophthalmology
  • 9.4.1. Cataract
  • 9.4.2. Glaucoma
  • 9.4.3. Retinal
• 9.5. Orthopedic
  • 9.5.1. Joint Replacement
    • 9.5.1.1. Knee Replacement
    • 9.5.1.2. Hip Replacement
  • 9.5.2. Spine Procedures
  • 9.5.3. Trauma Fixation

10. Surgical Procedures Market, by End User

• 10.1. Ambulatory Surgical Center
• 10.2. Hospital
• 10.3. Specialty Clinic
• 10.4. Research & Academic Institution

11. Surgical Procedures Market, by Region

• 11.1. Asia-Pacific
• 11.2. North America
• 11.3. Latin America
• 11.4. Europe
• 11.5. Middle East
• 11.6. Africa

12. Surgical Procedures Market, by Group

• 12.1. ASEAN
• 12.2. GCC
• 12.3. European Union
• 12.4. BRICS
• 12.5. G7
• 12.6. NATO

13. Surgical Procedures Market, by Country

• 13.1. United States
• 13.2. Canada
• 13.3. Mexico
• 13.4. Brazil
• 13.5. United Kingdom
• 13.6. Germany
• 13.7. France
• 13.8. Russia
• 13.9. Italy
• 13.10. Spain
• 13.11. China
• 13.12. India
• 13.13. Japan
• 13.14. Australia
• 13.15. South Korea

14. Competitive Landscape

• 14.1. Market Concentration Analysis, 2025
  • 14.1.1. Concentration Ratio (CR)
  • 14.1.2. Herfindahl Hirschman Index (HHI)
• 14.2. Recent Developments & Impact Analysis, 2025
• 14.3. Product Portfolio Analysis, 2025
• 14.4. Benchmarking Analysis, 2025

15. Company Profiles

• 15.1. Johnson & Johnson Services, Inc.
• 15.2. Medtronic PLC
• 15.3. Stryker Corporation
• 15.4. Abbott Laboratories
• 15.5. Boston Scientific Corporation
• 15.6. Koninklijke Philips N.V.
• 15.7. GE HealthCare Technologies Inc.
• 15.8. Intuitive Surgical Operations, Inc.
• 15.9. Zimmer Biomet Holdings, Inc.
• 15.10. B. Braun SE
• 15.11. Alcon Vision LLC
• 15.12. Terumo Corporation
• 15.13. Becton, Dickinson & Company
• 15.14. Smith & Nephew PLC
• 15.15. Edwards Lifesciences Corporation
• 15.16. STERIS plc
• 15.17. Baxter International Inc.
• 15.18. Fujifilm Holdings Corporation
• 15.19. Siemens Healthineers AG
• 15.20. Olympus Corporation
• 15.21. Dragerwerk AG & Co. KGaA
• 15.22. Enovis Corporation
• 15.23. Teleflex Incorporated
• 15.24. Hologic, Inc.
• 15.25. CooperSurgical Inc
• 15.26. Conmed Corporation.
• 15.27. Integra LifeSciences Corporation.
• 15.28. Shimadzu Corporation
• 15.29. Bioventus LLC.
• 15.30. Arthrex, Inc.
• 15.31. Coloplast Group
• 15.32. Cook Medical, Inc.
• 15.33. Getinge AB
• 15.34. Globus Medical, Inc.
• 15.35. Merit Medical Systems.
• 15.36. Thermo Fisher Scientific Inc.